Wellington Management Group LLP Has $72.39 Million Stock Position in Guardian Pharmacy Services, Inc. $GRDN

Wellington Management Group LLP lowered its position in Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 2.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,729,032 shares of the company’s stock after selling 36,087 shares during the period. Wellington Management Group LLP owned 3.47% of Guardian Pharmacy Services worth $72,395,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. Ranger Investment Management L.P. bought a new position in shares of Guardian Pharmacy Services in the second quarter worth about $7,263,000. Globeflex Capital L P acquired a new position in shares of Guardian Pharmacy Services in the 2nd quarter valued at $1,857,000. Great Lakes Advisors LLC acquired a new position in Guardian Pharmacy Services in the second quarter valued at about $788,000. Handelsbanken Fonder AB acquired a new stake in shares of Guardian Pharmacy Services in the 2nd quarter valued at approximately $511,000. Finally, Bank of America Corp DE raised its holdings in Guardian Pharmacy Services by 86.1% in the first quarter. Bank of America Corp DE now owns 128,048 shares of the company’s stock worth $4,822,000 after purchasing an additional 59,245 shares during the period.

Wall Street Analyst Weigh In

GRDN has been the topic of a number of research analyst reports. Bank of America raised their price target on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Wall Street Zen raised shares of Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research report on Sunday, August 9th. Weiss Ratings upgraded Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 20th. Truist Financial upped their price objective on Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. Finally, Zacks Research lowered shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Eight research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, Guardian Pharmacy Services currently has a consensus rating of “Moderate Buy” and a consensus target price of $43.83.

Guardian Pharmacy Services Trading Up 0.9%

Guardian Pharmacy Services stock opened at $39.24 on Thursday. The stock has a 50-day moving average price of $39.80 and a two-hundred day moving average price of $38.01. The company has a market capitalization of $1.95 billion, a PE ratio of 38.09, a P/E/G ratio of 2.01 and a beta of 0.06. Guardian Pharmacy Services, Inc. has a 12 month low of $23.14 and a 12 month high of $47.02.

Guardian Pharmacy Services (NYSE:GRDN) last posted its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.26 by $0.03. The firm had revenue of $351.77 million for the quarter, compared to analyst estimates of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. As a group, analysts predict that Guardian Pharmacy Services, Inc. will post 1.19 earnings per share for the current fiscal year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.